Current and future trials of the EORTC brain tumor group

Détails

ID Serval
serval:BIB_B809545E34D5
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Current and future trials of the EORTC brain tumor group
Périodique
Onkologie
Auteur(s)
van den Bent  M. J., Stupp  R., Brandes  A. A., Lacombe  D.
ISSN
0378-584X (Print)
Statut éditorial
Publié
Date de publication
06/2004
Volume
27
Numéro
3
Pages
246-50
Notes
Journal Article
Review --- Old month value: Jun
Résumé
The EORTC Brain Tumor Group (BTG) is dedicated to clinical research of neoplasms of the brain. In the past years the BTG has carried out phase II and phase III trials on glial tumors, brain metastases and primary CNS lymphomas. Future studies will investigate novel drugs in combination with chemo-radiotherapy in glioblastoma multiforme, radiotherapy in meningioma, and chemotherapy in medulloblastoma. The BTG will also start a new phase III trial on newly diagnosed low-grade glioma comparing radiotherapy to temozolomide. In all our trials translational research is getting more and more important, often this is one of the most important ways to get useful conclusions from clinical trials. The wide recognition of the importance of translational research for clinical trials and in particular with targeted therapies implies that this type of research will become a mandatory element in many of our future trials.
Mots-clé
Antineoplastic Agents/*therapeutic use Brain Neoplasms/*drug therapy/*radiotherapy Clinical Trials/*methods/*trends Combined Modality Therapy European Union Glioma/drug therapy/radiotherapy Humans
Pubmed
Web of science
Création de la notice
28/01/2008 8:39
Dernière modification de la notice
20/08/2019 15:26
Données d'usage